Jazz Pharmaceuticals JAZZ
$230.26 −$6.19 (-2.62%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $230.62 +0.16%
Open$235.19
Prev close$236.45
Day range$227.95 – $238.59
Volume984.7K
Market cap$14.78B
P/E (TTM)68.1
Dividend yield–
JAZZ Stock News
Headlines matching Jazz Pharmaceuticals or the JAZZ ticker, most recent first.
- Citi Initiates Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Announces Target Price $325
- Piper Sandler Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $310
- Goldman Sachs Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Raises Target Price to $337 Positive
- UBS Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $337
- UBS Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Raises Target Price to $337 Positive
- Barclays Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Raises Target Price to $271 Positive
- TD Cowen Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $300
- Truist Financial Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating
- CCORF Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $300
- Needham Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $310
- RBC Capital Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Raises Target Price to $299 Positive
- A Quick Look at Today's Ratings for Jazz Pharmaceuticals(JAZZ.US), With a Forecast Between $281 to $322
- Morgan Stanley Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $283
- A Quick Look at Today's Ratings for Jazz Pharmaceuticals(JAZZ.US), With a Forecast Between $283 to $315
- A Quick Look at Today's Ratings for Jazz Pharmaceuticals(JAZZ.US), With a Forecast Between $273 to $307
No comments yet — be the first to weigh in on JAZZ.
Sign in to join the discussion.